BUY Glenmark Pharmaceuticals — Prakash Gaba, 24 Aug 2026

BUYGlenmark Pharmaceuticals

Glenmark Pharmaceuticals share price target & all analyst calls

byPrakash GabaHorizon: NA (inferred Swing (≤2wk))24 Aug 2026via CNBC Awaaz.

Entry₹2,371.7Inferred

Target₹2,400

Total upside +1.19%

Stop loss₹2,355-0.70% risk

Exit₹2,40025 Aug 2026, 9:15 am

Target hit+1.19%0.00%upside left

Follow Prakash Gaba for new calls(30% target hit, 295 closed calls)Get alerts Watch GLENMARK for new buy/sell callsGet alerts See 2 active Swing calls on GLENMARK See 147 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 25 Aug 2026

4 supporting1 neutral1 opposing

Supports the BUY call (4)

3 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·24 Aug · today

Glenmark Pharmaceuticals Inc., USA has launched a new Calcium Gluconate Injection product in various strengths and vial sizes.

BSE · Company Update·21 Aug · 4d ago

Glenmark Pharmaceuticals has received approval from the U.S. FDA for its Fluticasone Propionate Nasal Spray, 0.05 mg (50 mcg)/spray.

BSE · Company Update·20 Aug · 5d ago

3 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·20 Aug · 5d ago

Neutral / worth noting (1)

Glenmark USA has agreed to a settlement of $15.28 million to resolve antitrust and consumer protection lawsuits related to price-fixing allegations. The company denies all allegations and states the s

BSE · Company Update·11 Aug · 2w ago

Weighs against the BUY call (1)

Glenmark Pharma US arm agrees to $15.28 million settlement with Humana over antitrust lawsuits

NewsCnbc-Tv18·12 Aug · 2w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Glenmark Pharmaceuticals

All analyst calls on Glenmark Pharmaceuticals

More from Prakash Gaba

Every call and its outcome